⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

SAB Biotherapeutics, Inc. Common Stock

$3.50
+0.08 (+2.34%)

Volume:

677.942K ($2.31M)

Market Capitalization:

$318.45M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

SAB Biotherapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

+0.09(+2.64%)
Open$3.41
Close$3.50
Low$3.41
Low Change0.00 (0.00%)
High$3.50
High Change+0.09 (+2.64%)
Range$0.09
Volume25.373K
Dollar Volume$88.81K

Regular Trading Hours

-0.05(-1.45%)
Open$3.45
Close$3.40
Low$3.38
Low Change-0.07 (-2.03%)
High$3.54
High Change+0.09 (+2.61%)
Range$0.16
Volume652.063K
Dollar Volume$2.22M

Premarket

-0.13(-3.71%)
Open$3.50
Close$3.37
Low$3.37
Low Change-0.13 (-3.71%)
High$3.50
High Change+0.00 (+0.00%)
Range$0.13
Volume506
Dollar Volume$1.71K

After Hours Yesterday

-0.04(-1.17%)
Open$3.42
Close$3.38
Low$3.38
Low Change-0.04 (-1.17%)
High$3.42
High Change+0.00 (+0.00%)
Range$0.04
Volume24.301K
Dollar Volume$82.14K

Regular Trading Hours Yesterday

-0.06(-1.72%)
Open$3.48
Close$3.42
Low$3.40
Low Change-0.09 (-2.44%)
High$3.53
High Change+0.05 (+1.44%)
Range$0.14
Volume295.06K
Dollar Volume$1.01M

Premarket Yesterday

-0.12(-3.43%)
Open$3.50
Close$3.38
Low$3.37
Low Change-0.13 (-3.71%)
High$3.50
High Change+0.00 (+0.00%)
Range$0.13
Volume1.548K
Dollar Volume$5.23K

SAB Biotherapeutics News

There is no current news for this stock at the moment.

SAB Biotherapeutics Top Trades

SAB Biotherapeutics's top trade so far today returned +5.04%, while the top short trade returned -3.95%.

SAB Biotherapeutics Moving Averages

5 Day Moving Average (SMA5)$3.59
10 Day Moving Average (SMA10)$3.69
20 Day Moving Average (SMA20)$3.72
50 Day Moving Average (SMA50)$3.71
100 Day Moving Average (SMA100)$3.70
200 Day Moving Average (SMA200)$3.82

SAB Biotherapeutics Statistics

Average Volume (30 Days)333.69K
P/E Ratio (Current)-8.09
EPS (Current)-$0.43
Dividend Yield0.00%
Free Cash Flow-$57.44M
Cash Ratio0.71
Current Ratio9.22
Quick Ratio9.22
Debt to Equity0.01
Enterprise Value$311.57M
EV to EBITDA-4.53
EV to Sales
Price to Book1.47
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.16%
Return on Equity-0.18%

SAB Biotherapeutics Stock Splits

There has been 1 stock split for SAB Biotherapeutics (SABS). The reverse stock split occured on January 5, 2024 and reduced the outstanding shares at a ratio of 10:1.

DateTypeRatio
Jan 5, 2024Reverse10:1

SAB Biotherapeutics Dividends

There have been no dividends for SAB Biotherapeutics (SABS).